Literature DB >> 21157118

Bepridil facilitates early termination of spiral-wave reentry in two-dimensional cardiac muscle through an increase of intercellular electrical coupling.

Hiroki Takanari1, Haruo Honjo, Yoshio Takemoto, Tomoyuki Suzuki, Sara Kato, Masahide Harada, Yusuke Okuno, Takashi Ashihara, Tobias Opthof, Ichiro Sakuma, Kaichiro Kamiya, Itsuo Kodama.   

Abstract

Bepridil is effective for conversion of atrial fibrillation to sinus rhythm and in the treatment of drug-refractory ventricular tachyarrhythmias. We investigated the effects of bepridil on electrophysiological properties and spiral-wave (SW) reentry in a 2-dimensional ventricular muscle layer of isolated rabbit hearts by optical mapping. Ventricular tachycardia (VT) induced in the presence of bepridil (1 µM) terminated earlier than in the control. Bepridil increased action potential duration (APD) by 5% - 8% under constant pacing and significantly increased the space constant. There was a linear relationship between the wavefront curvature (κ) and local conduction velocity: LCV = LCV₀ - D·κ (D, diffusion coefficient; LCV₀, LCV at κ = 0). Bepridil significantly increased D and LCV₀. The regression lines with and without bepridil crossed at κ = 20 - 40 cm⁻¹, resulting in a paradoxical decrease of LCV at κ > 40 cm⁻¹. Dye transfer assay in cultured rat cardiomyocytes confirmed that bepridil increased intercellular coupling. SW reentry in the presence of bepridil was characterized by decremental conduction near the rotation center, prominent drift, and self-termination by collision with boundaries. These results indicate that bepridil causes an increase of intercellular coupling and a moderate APD prolongation, and this combination compromises wavefront propagation near the rotation center of SW reentry, leading to its drift and early termination.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21157118     DOI: 10.1254/jphs.10233fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  4 in total

1.  Calmodulin/CaMKII inhibition improves intercellular communication and impulse propagation in the heart and is antiarrhythmic under conditions when fibrosis is absent.

Authors:  Hiroki Takanari; Vincent J A Bourgonje; Magda S C Fontes; Antonia J A Raaijmakers; Helen Driessen; John A Jansen; Roel van der Nagel; Bart Kok; Leonie van Stuijvenberg; Mohamed Boulaksil; Yoshio Takemoto; Masatoshi Yamazaki; Yukiomi Tsuji; Haruo Honjo; Kaichiro Kamiya; Itsuo Kodama; Mark E Anderson; Marcel A G van der Heyden; Harold V M van Rijen; Toon A B van Veen; Marc A Vos
Journal:  Cardiovasc Res       Date:  2016-06-29       Impact factor: 10.787

2.  Calmodulin/CaMKII inhibition improves intercellular communication and impulse propagation in the heart and is antiarrhythmic under conditions when fibrosis is absent.

Authors: 
Journal:  Cardiovasc Res       Date:  2017-12-01       Impact factor: 10.787

3.  Improving cardiac conduction with a skeletal muscle sodium channel by gene and cell therapy.

Authors:  Jia Lu; Hong-Zhan Wang; Zhiheng Jia; Joan Zuckerman; Zhongju Lu; Yuanjian Guo; Gerard J J Boink; Peter R Brink; Richard B Robinson; Emilia Entcheva; Ira S Cohen
Journal:  J Cardiovasc Pharmacol       Date:  2012-07       Impact factor: 3.105

4.  Anti-arrhythmic effect of verapamil is accompanied by preservation of cx43 protein in rat heart.

Authors:  Peng Zhou; Shu-Miao Zhang; Qiu-Lin Wang; Qi Wu; Mai Chen; Jian-Ming Pei
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.